[go: up one dir, main page]

ZA903944B - Pyrrolidone derivatives the process for their preparation and the pharmaceutical compositions containing them - Google Patents

Pyrrolidone derivatives the process for their preparation and the pharmaceutical compositions containing them

Info

Publication number
ZA903944B
ZA903944B ZA903944A ZA903944A ZA903944B ZA 903944 B ZA903944 B ZA 903944B ZA 903944 A ZA903944 A ZA 903944A ZA 903944 A ZA903944 A ZA 903944A ZA 903944 B ZA903944 B ZA 903944B
Authority
ZA
South Africa
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
pyrrolidone derivatives
pyrrolidone
Prior art date
Application number
ZA903944A
Inventor
Gilbert Regnier
Regnier Gilbert
Alain Dhainaut
Dhainaut Alain
Jean Lepagnol
Lepagnol Jean
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA903944B publication Critical patent/ZA903944B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

New pyrrolidone compounds of the formula: <IMAGE> in which: R is OR'', SR'' or N (R3R4) R' is optionally substituted alkyl or aryl, and the carbon in the 5-position of the pyrrolidone ring, which is substituted by CH2R has the R or S configuration. These new compounds and their physiologically tolerable salts may be used therapeutically especially in the treatment of asthenias, ischaemic syndromes and nervous disorders associated with normal or pathological ageing.
ZA903944A 1989-05-31 1990-05-22 Pyrrolidone derivatives the process for their preparation and the pharmaceutical compositions containing them ZA903944B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8907153A FR2647785B1 (en) 1989-05-31 1989-05-31 NOVEL PYRROLIDONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (1)

Publication Number Publication Date
ZA903944B true ZA903944B (en) 1991-03-27

Family

ID=9382204

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA903944A ZA903944B (en) 1989-05-31 1990-05-22 Pyrrolidone derivatives the process for their preparation and the pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US5066651A (en)
EP (1) EP0401093B1 (en)
JP (1) JPH0688972B2 (en)
AT (1) ATE119149T1 (en)
AU (1) AU617945B2 (en)
CA (1) CA2017044A1 (en)
DE (1) DE69017265T2 (en)
DK (1) DK0401093T3 (en)
ES (1) ES2071793T3 (en)
FR (1) FR2647785B1 (en)
IE (1) IE67060B1 (en)
NZ (1) NZ233618A (en)
OA (1) OA09451A (en)
PT (1) PT94196B (en)
ZA (1) ZA903944B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1770788A3 (en) 2005-09-29 2011-09-21 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device having oxide semiconductor layer and manufacturing method thereof
TWI613489B (en) 2008-12-03 2018-02-01 半導體能源研究所股份有限公司 Liquid crystal display device
KR102342672B1 (en) 2009-03-12 2021-12-24 가부시키가이샤 한도오따이 에네루기 켄큐쇼 Semiconductor device
TWI485781B (en) 2009-03-13 2015-05-21 Semiconductor Energy Lab Semiconductor device and method of manufacturing the same
BR112020023072A2 (en) * 2018-05-11 2021-02-02 Temple University-Of The Commonwealth System Of Higher Education new functionalized lactams as modulators of the 5-hydroxytryptamine 7 receptor and their method of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2553409B1 (en) * 1983-10-18 1986-04-18 Choay Sa NOVEL BENZENESULFONYL-LACTAMES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ACTIVE SUBSTANCE OF PHARMACEUTICAL COMPOSITIONS
DK167393B1 (en) * 1985-12-30 1993-10-25 Roussel Uclaf 1-SULPHONYL-2-OXO-PYRROLIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
EP0373226B1 (en) * 1988-04-15 1994-06-15 Taiho Pharmaceutical Company, Limited Carbamoyl-2-pyrrolidinone compounds

Also Published As

Publication number Publication date
CA2017044A1 (en) 1990-11-30
EP0401093B1 (en) 1995-03-01
NZ233618A (en) 1991-11-26
EP0401093A1 (en) 1990-12-05
AU617945B2 (en) 1991-12-05
DE69017265D1 (en) 1995-04-06
IE901934L (en) 1990-11-30
ATE119149T1 (en) 1995-03-15
PT94196B (en) 1996-12-31
US5066651A (en) 1991-11-19
JPH0688972B2 (en) 1994-11-09
PT94196A (en) 1991-02-08
DK0401093T3 (en) 1995-07-10
FR2647785B1 (en) 1991-09-06
JPH0320259A (en) 1991-01-29
ES2071793T3 (en) 1995-07-01
IE67060B1 (en) 1996-02-21
DE69017265T2 (en) 1995-10-19
AU5608790A (en) 1990-12-06
OA09451A (en) 1992-10-15
FR2647785A1 (en) 1990-12-07

Similar Documents

Publication Publication Date Title
EG20218A (en) Process for preparing of substituted 3 aminoquinuclidines
IL76457A0 (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
CA2258949A1 (en) Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
FI102756B1 (en) Process for preparing therapeutically utilizable 6H- benzofuro[3a,3,3-ef][2]benzazepine derivatives
GB9024730D0 (en) Diazine derivatives
GR3020866T3 (en) Indolocarbazole derivatives, processes for their preparation and their use
FI92320C (en) Process for the preparation of new therapeutically useful bisphenylalkylpiperazine derivatives
IL79910A (en) 5,7-dihydro-6-(thi)oxopyrrolo(2,3-f)benzimidazole,-benzothiazole and-benzoxazoles,6-imines thereof,their preparation and pharmaceutical compositions containing them
ZA903944B (en) Pyrrolidone derivatives the process for their preparation and the pharmaceutical compositions containing them
AU6690190A (en) New thiophene derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
IL85230A0 (en) 5-(3-alkyl-5-tert.butyl-4-hydroxy-phenyl)-2-amino-6h-1,3,4-thiadiazines,a process for the preparation thereof,pharmaceutical compositions containing same,and the use thereof
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
HUT34945A (en) Process for the production of new resorcionol-derivatives and of therapeutic prepartions containing them
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
ZA923502B (en) 1-amidoocthydropyrido[2,1-c][1,4]oxazine compounds, processes for preparing these and pharmaceutical compositions containing them
IT1248525B (en) Derivatives of eseridine useful for the treatment of diseases associated with cholinergic disorders, process for their preparation and pharmaceutical compositions which contain them